Health Department transfers 10.49 million to reinforce pharmaceutical benefits

The Department of Health has authorized a credit transfer of 10,489,796.00 euros within Chapter II to reinforce the program for healthcare, pharmaceutical, and complementary benefits. The operation, processed under file 10.034/2026, was formalized through the resolution of October 18, 2026, and is published in the Official Gazette of the Generalitat Valenciana (DOGV) no. 10492, dated November 12, 2026, in section III of administrative acts.

The resolution, signed in Valencia by the Regional Minister Marciano Gómez Gómez, responds to the need to “transfer credit between the same chapter of different programs in order to readjust budgetary availability.” According to the document, the Sub-directorate General for Economic Management reported that Chapter II of program 412B, for Healthcare, pharmaceutical, and complementary benefits, requires an increase in its allocation for the processing of certain contracts and extensions, as well as for the payment of outstanding obligations.

An internal operation without outflow of funds

The transfer does not incorporate new money into the Department: it is limited to moving credit between programs of the same Chapter II, which is destined for current expenditures on goods and services. The total amount is concentrated in a single receiving application, G.412B22.22199 of the managing center G01100201GESC000, which receives the 10,489,796.00 euros.

To justify the reduction, the resolution maintains that the credit being withdrawn “as of the current date, is not linked to pending commitments nor affected by conditioned financing” and that its reduction “has no impact whatsoever on the objectives of the affected programs.”

Three general directorates as the source of funds

The amount is covered by the available credit from the own funds of three managing centers, all of which are attached to general directorates that, according to the text, will not execute those amounts for the remainder of the fiscal year:

• General Directorate of Mental Health and Addictions: 10,000,000.00 euros, charged to position G.313B00.22799 (program 313B00, Mental health and addictions).
• General Directorate of Research and Innovation: 239,796.00 euros, charged to position G.411E00.22799 (program 411E00, Health sciences research).
• General Directorate of Health Information, Quality, and Evaluation: 250,000.00 euros, charged to position G.411F00.22707 (program 411F00, Planning and patient care).

The bulk of the operation therefore corresponds to the Mental Health and Addictions area, which provides 95.3% of the total transferred.

The regulatory backing of the transfer

The authorization is based on Law 4/2026, of July 22, on the budgets for the Generalitat for the 2026 financial year, and on Law 1/2015, of February 6, on public finance, the instrumental public sector, and subsidies. The text also invokes Decree 77/2019, of June 7, regulating the budget management procedure of the Generalitat.

The framework is completed by Decree 16/2025, of December 3, which establishes the number and name of the consellerias; Decree 186/2025, of December 5, on the basic organic structure of the Presidency and the consellerias, and Decree 22/2025, of February 11, which approves the Organic and Functional Regulations of the Conselleria of Health.

The resolution is published under the official reference DOGV-C-2026-33383 and is dated October 18, 2026, nearly a month before its appearance in the regional bulletin.

The budgetary movement comes at a time of pressure on pharmaceutical spending and will allow the Conselleria to address already awarded contracts and pending invoices before the close of the financial year. For pharmacies, distributors, and providers of the Valencian public health system, the operation represents a guarantee of coverage for the payment of obligations already contracted with the pharmaceutical and complementary benefits program.

Source: Diari Oficial de la Generalitat Valenciana, no. 10492, November 12, 2026, section III (administrative acts), Conselleria of Health (official reference: DOGV-C-2026-33383).